Drug Profile
Tigulixostat - LG Chem
Alternative Names: IBI-350; LC-350189; LR-19074Latest Information Update: 08 Jan 2024
Price :
$50
*
At a glance
- Originator LG Life Sciences
- Developer LG Chem
- Class Antigouts; Carboxylic acids; Indoles; Nitriles; Pyrazoles; Small molecules
- Mechanism of Action Xanthine oxidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase III Gout
Most Recent Events
- 30 Nov 2023 LG Chem completes phase I trials in Gout (In volunteers) (NCT06189404)
- 31 Oct 2023 LG Chem initiates a phase I trials in Gout (In volunteers) (NCT06189404)
- 30 Mar 2023 Phase-III clinical trials in Gout in USA (PO) (NCT05586971)